M. Trigg

J. Wagner, J. Kurtzberg, M. Trigg, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation

M. Trigg, R. Giller, F. Goldman, 1997, Clinical and diagnostic laboratory immunology.

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

Mei-Jie Zhang, David D. Smith, David D Smith, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Kaplan, V. Cool, S. Packman, 1996, Blood.

A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia.

P. Steinherz, M. Trigg, M. Cairo, 1982, The Journal of pediatrics.

Early testicular biopsy in males with acute lymphoblastic leukemia: lack of impact on subsequent event-free survival.

H. Sather, P. Steinherz, M. Trigg, 2000, Journal of pediatric hematology/oncology.

Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice

M. Trigg, G. Higa, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

John P Klein, Daniel J Weisdorf, Peter Greenberg, 2004, Blood.

Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.

N. Heerema, H. Sather, B. Lange, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

C. Pui, R. Gelber, E. Korn, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T‐cell phenotype or other poor prognostic features

H. Sather, F. Uckun, P. Steinherz, 1998, Cancer.

Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study.

H. Sather, D. Arthur, F. Uckun, 1996, Leukemia & lymphoma.

Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group.

P. Steinherz, M. Trigg, W. Bleyer, 1996, International journal of radiation oncology, biology, physics.

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

C. Pui, R. Peto, J. Peto, 1996, The Lancet.

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.

N. Heerema, H. Sather, B. Lange, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study

H. Sather, D. Arthur, F. Uckun, 1996 .

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

P. Hari, R. Kyle, D. Reece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.

S. Feig, H. Sather, M. Trigg, 1996, Medical and pediatric oncology.

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

H. Sather, P. Steinherz, M. Trigg, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.

D. Arthur, G. Reaman, F. Uckun, 1996, Blood.

Ten-year survival of children with acute lymphoblastic leukemia: A report from the Children's Oncology Group

H. Sather, G. Reaman, F. Uckun, 2008, Leukemia & lymphoma.

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

N. Heerema, H. Sather, M. Trigg, 2003, Blood.

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.

H. Sather, M. Sensel, M. Trigg, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.

D. Reardon, P. Davis, M. Trigg, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long Term Results of the Children’s Cancer Group Studies for Childhood Acute Lymphoblastic Leukemia 1983–2002: a Children’s Oncology Group Report

H. Sather, S. Hunger, A. Angiolillo, 2009, Leukemia.

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia : Children ’ s Oncology Group Study AALL 0031

M. Devidas, M. Trigg, W. Bowman, 2015 .

Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.

N. Heerema, H. Sather, M. Trigg, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

N. Heerema, S. Hunger, M. Borowitz, 2014, Leukemia.

Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031

N. Heerema, M. Devidas, A. Carroll, 2014, Leukemia.

Aniridia and Wilms' tumor in a child constitutionally mosaic for 11p-;12q+: a new chromosomal change also present in Wilms' tumor cells of the blastema type.

M. Trigg, E. Gilbert, D. Uehling, 1986, Human pathology.

Obesity and Body Weight Independently Predict Relapse and Survival in Preadolescents and Teenagers with Acute Lymphoblastic Leukemia (ALL). A Retrospective Analysis of Five Children Cancer Group (CCG) Studies.

A. Bleyer, H. Sather, B. Lange, 2004 .

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.

N. Heerema, L. Robison, H. Sather, 2005, Blood.

Thymus and B cell reconstitution in severe combined immunodeficiency after transplantation of monoclonal antibody depleted parental mismatched bone marrow.

M. Trigg, P. Sondel, S. Horowitz, 1987, Bone marrow transplantation.

Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.

N. Heerema, S. Bertolone, H. Sather, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.

H. Sather, D. Arthur, G. Reaman, 1997, Leukemia & lymphoma.

Study CD2+CD19+ Acute Lymphoblastic Leukemia: A Children's Cancer Group Clinical Features and Treatment Outcome of Children With Biphenotypic

H. Sather, D. Arthur, F. Uckun, 2013 .

Cancer Group Positive Acute Lymphoblastic Leukemia: A Report From the Children's Clinical Features and Treatment Outcome of Children With Myeloid Antigen

H. Sather, D. Arthur, G. Reaman, 2012 .

risk B-lineage acute lymphoblastic leukemia Leukemic cell growth in SCID mice as a predictor of relapse in high-

A. Bleyer, H. Sather, G. Reaman, 2011 .

Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.

H. Sather, D. Arthur, G. Reaman, 1997, Blood.

Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.

A. Bleyer, J. Shuster, H. Sather, 1995, Blood.

Actuarial risk of isolated CNS involvement in Ewing's sarcoma following prophylactic cranial irradiation and intrathecal methotrexate.

R. Makuch, M. Trigg, D. Glaubiger, 1985, International journal of radiation oncology, biology, physics.

Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens.

J. Finlay, M. Trigg, L. Meisner, 1986, Experimental hematology.

Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection.

B. Flynn, M. Trigg, J. Hank, 1985, Experimental hematology.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG‐1941)

David Steele, D. Stram, M. Trigg, 2006, Pediatric blood & cancer.

Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation.

M. Trigg, R. Gingrich, R. Giller, 1989, Bone marrow transplantation.

Preparative Therapies Used for those with Fanconi's Anemia Undergoing Stem Cell Transplants and Subsequent Engraftment Rates

M. Trigg, R. Bond, 2003, Hematology.

Milestones in the development of pediatric hematopoietic stem cell transplantation—50 years of progress

M. Trigg, 2002, Pediatric transplantation.

Administration of recombinant human granulocyte‐macrophage colony‐stimulating factor to children undergoing allogeneic marrow transplantation: A prospective, randomized, double‐masked,placebo‐controlled trial

M. Trigg, M. Zimmerman, C. Peters, 2000, Pediatric transplantation.

Survival after relapse in childhood acute lymphoblastic leukemia

P. Steinherz, M. Trigg, P. Gaynon, 1998, Cancer.

Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome

M. Trigg, S. Horowitz, R. Hong, 1990 .

Post-transplant immune recovery and the implication for infection risk

M. Trigg, 2002, International journal of hematology.

Can we make some general recommendations regarding immune recovery after hematopoietic reconstitution preceded by ablative therapy?

M. Trigg, 1999, Pediatric transplantation.

Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens

M. Trigg, D. Inverso, 2008, Bone Marrow Transplantation.

Bone marrow transplantation using alternative donors. Mismatched related donors or closely matched unrelated donors.

M. Trigg, 1993, The American journal of pediatric hematology/oncology.

The sources and uses of hematopoietic stem cells keep increasing.

M. Trigg, 1998, Delaware medical journal.

In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.

J. Finlay, M. Trigg, J. Hank, 1986, Cancer research.

Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the "graft versus leukemia" effect.

M. Trigg, J. Hank, P. Sondel, 1985, Experimental hematology.

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

N. Heerema, H. Sather, B. Lange, 2002, Blood.

Severe hemorrhagic cystitis

M. Trigg, M. Comito, Dr M. E. Trigg, 1993, International Urogynecology Journal.

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.

N. Heerema, L. Robison, H. Sather, 2002, Blood.

The frequency of isolated CNS involvement in Ewing's Sarcoma

M. Trigg, M. Nesbit, D. Glaubiger, 1982, Cancer.

Mechanisms of action of commonly used drugs to treat cancer

M. Trigg, Anne Flanigan-Minnick, 2011 .

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

J. Klein, R. Gale, M. Trigg, 2002, British journal of haematology.

Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings.

W. Yuh, Y. Sato, N. Mayr, 1994, AJR. American journal of roentgenology.

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

N. Heerema, H. Sather, S. Hunger, 2007 .

Rapid epidemiologic characterization of cytomegalovirus strains from pediatric bone marrow transplant patients.

J. Bale, M. Trigg, T. Haugen, 1995 .

Rapid Epidemiologic Characterization of Cytomegalovirus Strains From Pediatric Bone Marrow Transplant Patients

M. Trigg, T. Haugen, I. Souza, 1995, Infection Control & Hospital Epidemiology.

Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis.

M. Trigg, J. Kemp, D. Davey, 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Tracheal aspirate examination for Pneumocystis carinii cysts as a guide to therapy in pneumocystis pneumonia.

M. Trigg, D. Kohn, P. Chesney, 1983, The Journal of pediatrics.

Diagnostic X-rays and ultrasound exposure and risk of childhood acute lymphoblastic leukemia by immunophenotype.

J. Potter, X. Shu, L. Robison, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Alpha-interferon therapy for lymphoproliferative disorders developing in two children following bone marrow transplants.

M. Trigg, R. Giller, P. D. de Alarcon, 1989, Journal of biological response modifiers.

Intensification o f T herapy f or C hildren W ith L ower-Risk A cute Lymphoblastic L eukemia: L ong-Term F ollow-Up o f P atients Treated o n C hildren's C ancer G roup T rial 1 881

N. Heerema, S. Bertolone, H. Sather, 2003 .

LOW MATERNAL SERUM AFP AND DOWN SYNDROME

B. No̸rgaard-Pedersen, M. Trigg, A. Tabor, 1984, The Lancet.

Metastasis of an optic glioma through a ventriculoperitoneal shunt

M. Trigg, J. Swanson, M. Letellier, 1983, Cancer.

Human G ranulocyte C olony-Stimulati ng F actor i n C hildren With H igh-Risk A cute L ymphoblastic L eukemia: A C hildren's Cancer G roup S tudy

S. Jhanwar, H. Sather, J. A. Heath, 2003 .

SARCOIDOSIS PRESENTING AS SCROTAL MASS

M. Trigg, D. Kohn, P. Chesney, 1985, Pediatric Infectious Disease.